CT-Angiography Prior to DIEP Flap Breast Reconstruction
1 other identifier
interventional
39
1 country
1
Brief Summary
This study will Investigate whether or not preoperative computed tomography (CT) angiography will lower operative times and post operative complications for breast reconstruction performed with a deep inferior epigastric artery perforator flap (DIEP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Sep 2016
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2016
CompletedFirst Posted
Study publicly available on registry
August 30, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedFebruary 24, 2022
February 1, 2022
3.5 years
August 25, 2016
February 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Operative Time
Time required to perform breast reconstruction with DIEP flap
Time of incision to incision closure
Study Arms (2)
Preoperative CT Angiography
EXPERIMENTALPatients will receive preoperative CT angiography to map the blood vessels potentially used for reconstruction
No Imaging Preoperatively
ACTIVE COMPARATORNo preoperative vessel mapping will be done
Interventions
Patients will receive a CT scan to map the blood vessels to be used during surgery for breast reconstruction
No imaging will be done to map blood vessels prior to surgery
Eligibility Criteria
You may qualify if:
- Planning breast reconstruction with DIEP flap
- Age 18 to 75 years
You may not qualify if:
- Mild to moderate loss of kidney function (Estimated Glomerular Filtration Rate (eGFR) \< 60)
- Decisionally challenged
- Pregnant
- Hepatic failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David W Mathes, MD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2016
First Posted
August 30, 2016
Study Start
September 1, 2016
Primary Completion
March 1, 2020
Study Completion
March 1, 2020
Last Updated
February 24, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share